Hyundai Motor Stock Plunges, Fundamentals Unchanged... For Robot Stocks, Only Look at 'These Types of Stocks' | Director Lee Young-hoon
Speakers
Lee Young-hoon
— Director
Oh Hyun-jin
— Team Lead
Summary
Director Lee Young-hoon discusses Korean robot stock selection through large group value chains, argues Hyundai Motor Group's share drop was supply-driven and still positive, says KOSDAQ upside requires real government policy and prefers KOSPI relatively, views nuclear as rotation-only but solar/polysilicon as more attractive, and sees Korean biotech as bottoming.
- Robot investing should focus on Hyundai Motor Group and LG Group affiliate value chains; Samsung is a watch item until performance is proven.
- Hyundai Motor Group fundamentals are unchanged; leveraged ETF supply distortions caused the drop, while robotics, autonomous driving, and UAM keep upside open.
- Hyundai Motor preferred shares are unattractive unless dividends rise materially.
- KOSDAQ needs meaningful government policy and catalysts; KOSPI relative merit is better near term.
- Selected Korean biotech names are bottoming, led by Alteogen's valuation and patent runway.
- Nuclear power may see rotation but lacks conditions to lead again soon.
- Solar/polysilicon is preferred over nuclear due China/US supply actions and long-term contract visibility.
Ideas
Focus robot stocks on group-linked value chains.
Korean humanoid robot investing should focus on large Korean conglomerates and their value chains, especially Hyundai Motor Group and LG Group now, with Samsung Group to watch once it demonstrates real humanoid performance. Pure-play Korean humanoid firms have not shown credible technical demonstrations, while Korea's economy is group-centered, government policy is promoting humanoid robots, and defense/dangerous-site demand should expand. Robot businesses will become concrete mainly through groups and their parts suppliers.
Focus robot stocks on group-linked value chains.
Korean humanoid robot investing should focus on large Korean conglomerates and their value chains, especially Hyundai Motor Group and LG Group now, with Samsung Group to watch once it demonstrates real humanoid performance. Pure-play Korean humanoid firms have not shown credible technical demonstrations, while Korea's economy is group-centered, government policy is promoting humanoid robots, and defense/dangerous-site demand should expand. Robot businesses will become concrete mainly through groups and their parts suppliers.
Focus robot stocks on group-linked value chains.
Korean humanoid robot investing should focus on large Korean conglomerates and their value chains, especially Hyundai Motor Group and LG Group now, with Samsung Group to watch once it demonstrates real humanoid performance. Pure-play Korean humanoid firms have not shown credible technical demonstrations, while Korea's economy is group-centered, government policy is promoting humanoid robots, and defense/dangerous-site demand should expand. Robot businesses will become concrete mainly through groups and their parts suppliers.
Hyundai Motor Group upside remains intact.
Hyundai Motor Group shares fell because leveraged ETF-driven supply/demand distortions broke positioning, not because fundamentals changed. The group is still actively pushing robotics with suppliers, Boston Dynamics is a globally leading humanoid asset, autonomous driving via Motional/42dot/Waymo collaboration and UAM are future optionality, so common shares have open upside. Shareholder return expansion may be limited, but governance restructuring momentum can support related stocks.
Avoid Hyundai Motor preferred versus common.
Hyundai Motor preferred shares are unlikely to outperform common because the dividend was cut for the first time in five years, large dividend increases are not expected, and common share upside is now open via robots, autonomous driving, and UAM. Preferred shares historically had merit when common upside was capped and dividend yields were high, but now their performance should lag absent much larger dividends; governance restructuring is the better way to play the group.
KOSPI likely beats KOSDAQ without policy.
KOSDAQ needs concrete government policy, not penny-stock delisting gimmicks but activation measures and listing-tier rules, to generate additional upside. Earnings and relative merit still favor KOSPI over KOSDAQ, so KOSDAQ is likely to move mainly through rotational flows when leading stocks rest or when biotech/materials/parts names get individual momentum.
KOSPI likely beats KOSDAQ without policy.
KOSDAQ needs concrete government policy, not penny-stock delisting gimmicks but activation measures and listing-tier rules, to generate additional upside. Earnings and relative merit still favor KOSPI over KOSDAQ, so KOSDAQ is likely to move mainly through rotational flows when leading stocks rest or when biotech/materials/parts names get individual momentum.
Korean biotech bottom is confirmed.
Korean biotech has likely confirmed a bottom. Alteogen's market-cap convergence with a large-cap peer was unreasonable because Alteogen's patent runway and current/expected licensing deals should keep expanding its revenue pool; another biotech name that received government growth-fund preferred funding fell from the 97,400 won minimum issue price toward 70,000 won, which the speaker also sees as unreasonable. Since biotech often moves as a group via ETF/passive flows, individual catalysts can lift the sector.
Nuclear stocks are rotation only, not leading.
Nuclear-related shares can participate as a rotation/momentum theme, and foreign supply/demand for Doosan Enerbility was intense in the past, but valuations remain extreme and the trapped supply needs more concrete fundamentals/catalysts before the group can lead again. Near-term expectations for another explosive rally are low.
Solar/polysilicon preferred over nuclear now.
Solar and polysilicon are more attractive than nuclear now because China has restricted loss-making polysilicon exports, the US is strengthening barriers against Chinese supply, and conference-call long-term supply agreements are based on data that makes analysts project a sharp profit jump for related companies. Power shortages and faster installation timelines than nuclear add visibility, though he is not yet aggressively adding.
Up Next
This 815 Money Talk (815머니톡) video, published August 16, 2026, features Lee Young-hoon discussing LG Group, Hyundai Motor Group, Samsung Group, Korean pure-play humanoid stocks, 012330.KS, 005380.KS, 005385.KS, KOSDAQ, EWY, Korean biotech sector, 196170.KQ, KORU, 034020.KS, TAN. 10 trade ideas extracted by AI with direction and confidence scoring.
Speakers: Lee Young-hoon · Tickers: LG Group, Hyundai Motor Group, Samsung Group, Korean pure-play humanoid stocks, 012330.KS, 005380.KS, 005385.KS, KOSDAQ, EWY, Korean biotech sector, 196170.KQ, KORU, 034020.KS, TAN